Genetic Signatures Ltd. (AU:GSS) has released an update.
Genetic Signatures Limited, listed as GSS on the ASX, has applied for the quotation of 300,000 new fully paid ordinary shares on September 30, 2024. This move indicates an expansion of the company’s securities in the financial market, offering potential investors a new opportunity for investment in the biotechnology sector.
For further insights into AU:GSS stock, check out TipRanks’ Stock Analysis page.